Search - tctmd.com

Displaying 821 - 840 of 1456

Sort: Relevancy | Date

News Industry News

AtriCure Launches the AtriClip® FLEX•V™ Device in the United States

February 23, 2018

Presentation JIM 2018

Combo Mitral & LAA: Ready for prime time?

Presenter: Giuseppe Tarantini

February 22, 2018

Presentation JIM 2018

The Ultraseal LAA Experience

Presenter: Jai-Wun Park

February 22, 2018

Presentation JIM 2018

Is It Time to Expand LAA Indication?

Presenter: Sergio Berti

February 22, 2018

Podcast TCTMD Talking Points

PREVAIL: 5-Year Outcomes Following Left Atrial Appendage Closure in Patients With Non-Valvular Atrial Fibrillation

February 21, 2018

News Daily News

More Data Hint at the Superiority of 3D Imaging for LAA Occlusion

Yael L. Maxwell

February 08, 2018

News Daily News

Largest Study to Date Supports Surgical LAA Closure in A-fib Patients

Shelley Wood

January 23, 2018

News Daily News

Is TEE Necessary for LAA Occlusion? Maybe Not

Todd Neale

January 15, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2017

Shelley Wood

November 29, 2017

News Conference News AHA 2017

‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry

Todd Neale

November 22, 2017

News Conference News TCT 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Todd Neale

November 02, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Four

Shelley Wood

November 02, 2017

Presentation TCT 2017

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Presenter: Samir R. Kapadia, David J. Moliterno

November 01, 2017

Presentation TCT 2017

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Presenter: Samir R. Kapadia, Sameer Gafoor

November 01, 2017

Presentation TCT 2017

Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset

Presenter: Samir R. Kapadia, Brian K. Whisenant

November 01, 2017

Presentation TCT 2017

Rationale and Potential Role for LAA Closure in the PCI and ACS Patient

Presenter: Samir R. Kapadia, Ashish Pershad

November 01, 2017

Presentation TCT 2017

Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial)

Presenter: Samir R. Kapadia

November 01, 2017

Presentation TCT 2017

My Most Challenging LAA Closure Case: Twice As Many Problems As Usual

Presenter: Matthew J. Price, Jacqueline Saw, Petr Neuzil

October 31, 2017

Presentation TCT 2017

Medical Treatment After LAA Closure: Trade-off of Bleeding vs Device-Related Thrombus

Presenter: Matthew J. Price, Jacqueline Saw, Lucas V. Boersma

October 31, 2017

Presentation TCT 2017

Residual Leaks After LAA Closure: Frequency, Prevention, and Treatment (With Case Reviews)

Presenter: Matthew J. Price, Jacqueline Saw, Kolja Sievert

October 31, 2017

Advertisement

AtriCure Launches the AtriClip® FLEX•V™ Device in the United States

Combo Mitral & LAA: Ready for prime time?

The Ultraseal LAA Experience

Is It Time to Expand LAA Indication?

PREVAIL: 5-Year Outcomes Following Left Atrial Appendage Closure in Patients With Non-Valvular Atrial Fibrillation

More Data Hint at the Superiority of 3D Imaging for LAA Occlusion

Largest Study to Date Supports Surgical LAA Closure in A-fib Patients

Is TEE Necessary for LAA Occlusion? Maybe Not

TCTMD’s Top 10 Most Popular Stories for November 2017

‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Live From Denver: TCT 2017, Day Four

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset

Rationale and Potential Role for LAA Closure in the PCI and ACS Patient

Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial)

My Most Challenging LAA Closure Case: Twice As Many Problems As Usual

Medical Treatment After LAA Closure: Trade-off of Bleeding vs Device-Related Thrombus

Residual Leaks After LAA Closure: Frequency, Prevention, and Treatment (With Case Reviews)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content